MIBHS

FEBRUARY 28, 2025

Maintain a Healthy Weight: Obesity amplifies the effects of genetic predispositions by contributing to high cholesterol, hypertension, and diabetes. Gene-Based Interventions and Personalized Medicine As research continues to evolve, new treatments tailored to individuals’ genetic profiles are becoming available.

Genetic predisposition

HCPLive

JUNE 15, 2025

Further research with larger sample sizes is needed to validate these findings and enhance diagnostic capabilities. What little research has been conducted indicates that glaucoma conversion is twice as high in patients with pseudoexfoliation as without.

Research

HCPLive

JULY 2, 2025

Image Credit: US Food and Drug Administration The US Food and Drug Administration (FDA) has granted priority review to a supplemental Biologics License Application (sBLA) aiming to update the US product label for sotatercept-csrk (WINREVAIR)to treat pulmonary arterial hypertension (PAH, Group 1 PH). 3 References Merck Research Laboratories.

Laboratory

DAIC

APRIL 22, 2025

tim.hodson Tue, 04/22/2025 - 09:55 April 22, 2025 Research teams from Augusta University, Massachusetts General Hospital and The Ohio State University will lead a $15 million project dedicated to studying the various ways that risk factors for cardiovascular and kidney diseases impact women.

Research

HCPLive

JUNE 23, 2025

Vallerie McLaughlin, MD | Image Credit: Michigan Medicine, University of Michigan Merck has announced positive topline results from the Phase 3 HYPERION trial for sotatercept-csrk (WINREVAIR) in treating pulmonary arterial hypertension (PAH) functional class (FC) II or III at intermediate or high risk of disease progression.

Pulmonary

Frontiers in Cardiovascular Medicine

FEBRUARY 10, 2025

The robustness of the results was verified by subgroup and sensitivity analyses.ResultsA cohort of 11,556 people with a diagnosis of hypertension was included in this study.

Hypertension

Cardiometabolic Health Congress

MAY 6, 2025

Confronting the Silent Killer: Advancing Hypertension Awareness and Action May is High Blood Pressure Education Month Its time to elevate awareness around hypertensionthe silent killer affecting millions of Americansand in support, were offering a special incentive to attend this years annual Cardiometabolic Health Congress (CMHC) in Boston.

Blog

Cardiometabolic Health Congress

JANUARY 15, 2025

This imbalance is partly due to limited healthcare access, fewer preventive resources, and challenges in addressing risk factors such as obesity and diabetes. For example, the global spread of obesity, particularly among youth, has set the stage for a future pandemic of non-communicable diseases.

Atherosclerosis

European Journal of Heart Failure

APRIL 13, 2025

Patients with COPD had a higher risk of the primary endpoint (adjusted rate ratio [RR] 1.44, 95% confidence interval [CI] 1.211.71).

Preserved Ejection Fraction

HCPLive

JUNE 24, 2025

These findings were presented by Subodh Verma, MD, PhD, cardiac surgeon-scientist and Professor at University of Toronto and Tier 1 Canada Research Chair in Cardiovascular Surgery, at the 2025 American Diabetes Association (ADA) Scientific Sessions , held June 20-23, in Chicago, Illinois. in the semaglutide group compared to 1.08

Diabetes

Physiologically Speaking

FEBRUARY 14, 2025

They had lower risks of hypertension, diabetes, dementia, stroke, Parkinson’s disease, obesity, sleep apnea, and other chronic health conditions compared to inactive adults and similar risks compared to adults accruing their weekly exercise in a greater number of days. But a new study from Tripp et al.

Physiology

Heart BMJ

JUNE 13, 2025

The European Society of Cardiology (ESC) Guidelines for the management of AF specifically highlight the need to focus on coexistent hypertension, heart failure, diabetes mellitus, obesity and sleep apnoea.

Atrial Fibrillation

Cardiometabolic Health Congress

NOVEMBER 14, 2024

42% of adults are considered obese , increasing their risk of diabetes, hypertension, and cardiovascular issues. Additionally, 10% of the global population suffers from chronic kidney disease , with diabetes and hypertension as significant risk factors. In the U.S., SELECT Trial Results : Semaglutide 2.4

Obesity

HCPLive

JULY 8, 2025

The condition often appears as hyperlipidemia, hypertension, coronary artery disease, type 2 diabetes, and increased body mass index (BMI). The condition often appears as hyperlipidemia, hypertension, coronary artery disease, type 2 diabetes, and increased body mass index (BMI).

Blood Pressure

CardiacWire

JULY 11, 2025

Searching for trends in CV mortality , Stanford researchers analyzed over 50 years of CDC data, revealing dramatic changes in cardiac mortality patterns among American adults. Hypertensive heart disease mortality rose 106%. However, there’s one critical factor to keep in mind – obesity. Where do we go from here?

Heart Disease

HCPLive

JUNE 22, 2025

1 For inclusion, patients need to be adults with a BMI of 30 kg/m2 or greater, or 27 or greater with at least one obesity-related comorbidity, such as hypertension, dyslipidemia, or obstructive sleep apnea. of patients receiving CagriSema reached the BMI threshold for non-obesity by the end of the trial relative to 10.2%

Obesity

HCPLive

JUNE 20, 2025

Pedro Ochoa-Allemant, MD Credit: Pedro Ochoa-Allemant on Linkedin New research is shedding light on differents in long-term adverse outcomes across steatotic liver disease subtypes, highlighting the importance of alcohol use and fibrosis assessments for identifying high risk individuals. per 100 person-years; HR, 2.33; 95% CI, 2.20-2.47)

Outcomes

HCPLive

JULY 10, 2025

The study suggests that transient ischemic attacks may not significantly increase dementia risk, but further research is needed to clarify cognitive impacts. SHOW MORE Contrary to earlier research, a Framingham Heart Study analysis found no significant dementia risk tied to transient ischemic attack over 2 decades.

Dementia

HCPLive

JULY 1, 2025

Treprostinil palmitil inhalation powder showed significant outcome improvements for pulmonary arterial hypertension, supporting its potential as an effective prostanoid therapy. SHOW MORE June 2025 saw more research emerge in asthma therapeutics and management as well as rarer pulmonary diseases.

Pulmonary

HCPLive

JUNE 24, 2025

Hung is known for her role as director of the IBD Program at Sinai Health System Chicago and as a clinical assistant professor at the Rosalind Franklin University Medical School.

Diabetes

HCPLive

JULY 2, 2025

SHOW MORE Q2 2025 saw more research emerge in asthma therapeutics and management as well as rarer pulmonary diseases. Check out this June 2025 pulmonology month in review for a recap of HCPLive’s coverage of the top pulmonary news and research from the past few weeks: Biologics Garnered More Positive Data in COPD 1.

Pulmonary

HCPLive

JUNE 24, 2025

Chovatiya serves as a clinical associate professor at Rosalind Franklin University Chicago Medical School and director of the Center for Medical Dermatology and Immunology Research. Ultimately, the episode reinforces that interdisciplinary care not only improves patient outcomes, but strengthens trust and continuity across specialties.

Diabetes

HCPLive

JULY 7, 2025

Other regulatory progress included FDA acceptance of a gene therapy BLA for recurrent respiratory papillomatosis, an ultrarare disease with no approved treatments, and encouraging steps toward new therapies for pulmonary arterial hypertension and progressive pulmonary fibrosis.

Pulmonary

HCPLive

JUNE 20, 2025

Sustained remission was defined by the researchers as complete clinical remission and successful tapering off of oral corticosteroids by the 16-week point in the study. Sustained remission was defined by the researchers as complete clinical remission and successful tapering off of oral corticosteroids by the 16-week point in the study.

CME

CardiacWire

FEBRUARY 11, 2024

The associations between obesity and hypertension are widely known, but a new JACC study reveals that weight-reducing gastric bypass surgery has a significant and lasting impact on patients’ need for antihypertensives. vs. 2.4%) All gastric bypass patients eliminated their resistant hypertension (from 15.2%

Hypertension

Cardiometabolic Health Congress

JANUARY 3, 2024

In today’s society, the prevalence of obesity has become a significant concern. have obesity, and this rate has increased by more than 10 percentage points in the past two decades. Understanding the prevalence of obesity is crucial in comprehending why events like Healthy Weight Week are essential. of adults in the U.S.

Obesity

Cardiovascular Diabetology

JANUARY 7, 2025

Among hypertensive cohorts across different nations, the relationship between the triglyceride-glucose index (TyG) and its conjunction with obesity metrics in relation to cardiovascular disease (CVD) incidence.

Obesity

CardiacWire

MAY 8, 2024

Officially published by the AHA six months ago, CKM syndrome defines the connections and risks associated with obesity, type 2 diabetes, chronic kidney disease, and cardiovascular disease. The researchers analyzed 2011-2020 NHANES survey results and laboratory measurements from 10,762 nationally representative US adults (47.3yr avg.

Kidney Disease

Cardiovascular Diabetology

JANUARY 23, 2025

Obesity, a major risk factor for cardiovascular disease (CVD), is associated with hypertension and vascular dysfunction. Perivascular adipose tissue (PVAT), a metabolically active tissue surrounding blood vess.

Obesity

DAIC

JUNE 18, 2024

A projected rise in heart disease and stroke – along with several key risk factors, including high blood pressure and obesity – is likely to triple related costs to $1.8 A projected rise in heart disease and stroke – along with several key risk factors, including high blood pressure and obesity – is likely to triple related costs to $1.8

Heart Disease

Journal of the American Heart Association

FEBRUARY 14, 2024

Driven by common pathophysiologic underpinnings (eg, inflammation and neurohormonal dysregulation), cardiovascular disease, cognitive impairment, and frailty also share the following risk factors: hypertension, diabetes, obesity, sedentary behavior, and tobacco use.

Cardiovascular Disease

European Journal of Heart Failure

DECEMBER 7, 2023

Increasing severity of obesity is associated with multiple characteristics that may contribute to the development or worsening of heart failure (HF) with preserved ejection fraction (HFpEF). Echocardiography demonstrated increased CO with obesity, but not estimated right atrial (RA) pressure or E/e′. Overall, 60.9%

Preserved Ejection Fraction

DAIC

APRIL 6, 2024

The Minneapolis Heart Institute Foundation (MHIF) is presenting leading research focused on trends in ST-elevation myocardial infarction (STEMI), the most severe form of a heart attack, at the American College of Cardiology’s Annual Scientific Session (ACC.24), 24), being held April 6-8 in Atltanta, GA.

Heart Attack

Circulation

NOVEMBER 11, 2024

Intro:Drug Development for Heart failure with Preserved Ejection Fraction (HFpEF) is a major challenge facing cardiovascular research due to its complex pathophysiology and existence of comorbidities, leading to recognize distinct HFpEF phenogroups. Circulation, Volume 150, Issue Suppl_1 , Page A4139791-A4139791, November 12, 2024.

Hypertension

Cardiovascular Diabetology

JANUARY 27, 2024

This study used a bidirectional 2-sample Mendelian randomization study to investigate the potential causal links between mtDNA copy number and cardiometabolic disease (obesity, hypertension, hyperlipidaemia, t.

Obesity

Cardiometabolic Health Congress

OCTOBER 18, 2024

Sleep and Cardiometabolic Risk Dr. Somers delves into the growing body of research connecting poor sleep with heightened cardiometabolic risk. There is a clear relationship between sleep deprivation and the development of conditions like obesity, diabetes, and hypertension.

Blood Pressure

Cardiovascular Diabetology

FEBRUARY 9, 2024

Metabolic syndrome is characterized as the co-occurrence of interrelated cardiovascular risk factors, including insulin resistance, hyperinsulinemia, abdominal obesity, dyslipidemia and hypertension. Once week.

Risk Factors